NHS customer case · Manchester

Supporting whole-person obesity care beyond the clinic

Royal Manchester Children’s Hospital is a North West specialist hub for children and young people living with severe obesity and related health complications.

Manchester’s own service evaluations show why this care has to extend beyond weight alone — addressing mental health, mobility, stigma, neurodevelopmental needs and the wider circumstances affecting each family.

Evira adds connected home monitoring and digital communication around this multidisciplinary model of care.

North West CEW hubPublished service researchWhole-person care

Manchester University NHS Foundation Trust

At a glance

200 / year

children and young people the RMCH CEW service has publicly described supporting each year

North West hub

Manchester University NHS Foundation Trust is listed by NHS England as a specialist CEW hub

2–18 years

the service supports children and young people experiencing complications associated with severe obesity

Multidisciplinary

medical, nursing, psychology, dietetic, physiotherapy and wider support expertise

The pathway challenge

Weight is only part of the picture

Children and young people referred to Manchester’s specialist obesity service often face challenges that extend well beyond weight itself.

Published research from Royal Manchester Children’s Hospital has documented mental health concerns, impaired mobility, neurodevelopmental needs, financial barriers to healthy lifestyles and significant weight-related stigma.

Effective treatment therefore cannot focus on BMI alone. It requires a personalised, biopsychosocial approach that understands what is making change difficult for each child and family.

Manchester service research

Understanding the barriers around severe obesity

A 2022 evaluation of patients attending Royal Manchester Children’s Hospital’s CEW service explored the barriers, experiences and motivations affecting families receiving specialist treatment.

64%

Reported weight-related bullying

Among respondents to the Manchester service survey.

48%

Uncomfortable talking about weight

Almost half of respondents said they felt uncomfortable discussing their weight.

44%

Negative impact on mental health

Reported that their weight had negatively affected their mental health.

44%

Mobility as a barrier

Reported mobility as a barrier to physical activity.

The evaluation also identified cost as an important barrier to both healthy eating and physical activity, while autism and learning difficulties could make standard approaches to diet and exercise more difficult.

Figures are from an early Manchester service survey presented at BSPED 2022 and describe respondents to that evaluation, not the entire current CEW population.

Read the published evaluation ↗

Published 2023 evaluation

Quality of life matters alongside weight

Manchester researchers subsequently examined health-related quality of life and mobility among young people attending the CEW service.

The evaluation found that social functioning showed the greatest impairment and that poorer quality of life was associated with increasing age and higher BMI-SDS.

Weight-related stigma was reported across the surveyed cohort, with name-calling, comments about body size and difficulty shopping for clothes among the most common experiences.

Social wellbeing

Social functioning showed the largest quality-of-life impairment in the evaluated cohort.

Weight stigma

The Manchester team identified stigma and bullying as important issues requiring active clinical attention.

Mobility

Reduced mobility was more strongly associated with older age and higher BMI-SDS.

The researchers concluded that treatment should address self-esteem, bullying, social functioning and mobility alongside conventional weight-management strategies.

View the BSPED 2023 evaluation ↗

The care model

A multidisciplinary response to complex needs

Royal Manchester Children’s Hospital has developed an established CEW multidisciplinary team to assess and treat children living with severe obesity and related complications.

The team brings together expertise across paediatric medicine, specialist nursing, psychology, physiotherapy, dietetics and wider support roles.

The service also provides regional expertise and works with other services across the North West.

Physical health

Assessing and treating complications associated with severe obesity.

Mental health

Recognising psychological wellbeing, self-esteem and stigma as part of treatment.

Movement and mobility

Supporting children whose mobility or physical function creates additional barriers.

Family and lifestyle

Developing practical approaches around nutrition, behaviour and family circumstances.

A North West hub

Specialist expertise across a regional network

Manchester University NHS Foundation Trust is one of the NHS England CEW hubs for the North West.

The regional network also includes Alder Hey Children’s NHS Foundation Trust as a hub and Lancashire Teaching Hospitals as a spoke service.

Public NHS information describes Manchester’s team as providing regional advice and education as well as direct specialist treatment, using a combination of face-to-face and virtual contact so specialist expertise reaches families across a wider geography.

Source 3

In practice

Flexible care around individual need

Specialist assessment

Children receive holistic assessment of the complications and wider factors associated with severe obesity.

Individualised MDT support

The mix of clinical input can differ according to each child’s physical, psychological and social needs.

Face-to-face care

In-person specialist assessment and monitoring remain an important part of the pathway.

Virtual contact

Remote interactions can complement hospital appointments and make ongoing specialist support more flexible.

This approach closely reflects current NHS England guidance, which recommends individualised biopsychosocial treatment and flexible access through face-to-face, virtual and other remote formats.

Source 4

Early service evaluation

Early evidence from the Manchester pathway

Manchester’s initial 2022 service evaluation also reported short-term anthropometric outcomes for a small group of patients returning for three-month review.

−0.12

Mean BMI-SDS change at three months, reported among 12 patients with follow-up measurements.

The evaluation was small and designed primarily to understand patient experiences and barriers to treatment. The BMI result should therefore be treated as an early service observation rather than evidence of comparative effectiveness.

This evaluation predates or is independent of the current Evira implementation and must not be presented as an Evira outcome.

Read the published evaluation ↗

Where Evira fits

Maintaining continuity around whole-person care

Manchester’s published research shows that progress in specialist obesity care depends on much more than individual weight measurements.

Families may be navigating mental health challenges, mobility limitations, stigma, financial pressures and different levels of readiness for change.

Evira adds a digital layer around the existing multidisciplinary pathway: connected measurements provide an ongoing view of progress, while digital communication creates another way for families and clinicians to stay connected between scheduled interactions.

The purpose is not to replace specialist relationships, but to extend their continuity into everyday life.

At home

Families can collect regular measurements without daily weight numbers being displayed.

Over time

Progress can be viewed as a trajectory rather than isolated measurements.

Between appointments

Digital communication creates another channel for personalised feedback and support.

Person-centred care

Different families face different barriers

Manchester’s published experience illustrates why specialist childhood obesity treatment cannot be reduced to advice about diet, exercise or weight loss.

The barriers affecting an individual child may involve mental health, neurodevelopment, mobility, poverty, family circumstances or weight-related stigma.

Current NHS England commissioning guidance reflects this complexity, recommending individualised biopsychosocial care, reasonable adjustments for neurodiversity and flexible forms of engagement.

Digital support is most useful when it strengthens that personalised pathway rather than imposing a uniform model on every family.

The national model

Flexible specialist support over the long term

NHS England’s 2026 commissioning guidance describes CEW as specialist, tier 3-equivalent care delivered through a multidisciplinary biopsychosocial model.

Treatment is expected to continue for long enough to achieve meaningful change — typically around 18 to 24 months — with the intensity and frequency of support tailored to clinical need.

The guidance explicitly supports remote contact through digital engagement tools where appropriate, alongside face-to-face clinical assessment and monitoring.

This is national commissioning guidance, not a Manchester-specific outcome.

Source 4

Public evidence

What Manchester has published

BSPED 2022

A review of patient outcomes and responses to weight management strategies used by the CEW service

Manchester-specific evidence on barriers, bullying, mental health, mobility, neurodevelopment and early BMI-SDS change.

Read the evaluation ↗

BSPED 2023

Evaluation of psychological and musculoskeletal outcomes in a tertiary weight management service at Royal Manchester Children’s Hospital

Manchester-specific evidence on quality of life, stigma, social functioning and mobility.

Read the evaluation ↗

NHS England

Complications from Excess Weight clinics for children

Confirms Manchester University NHS Foundation Trust as a North West CEW hub and describes the national specialist care model.

View the national CEW network ↗

NHS England

CEW commissioning toolkit — August 2026

Current guidance on biopsychosocial care, multidisciplinary working, neurodiversity, flexible access and digital engagement.

View commissioning guidance ↗

Sources and references

Manchester has not published Evira-specific clinical outcomes. The 2022 and 2023 evaluations describe the Manchester CEW service and the people it treats. Evira is presented as a digital continuity layer around that multidisciplinary pathway.

Part of the North West network